elotuzumab,dexamethasone
abbvie,bms
['mmsm', 'elotuzumab', 'krd ']
#asco23 | stefan knop, , presents the results of elo-krd vs krd induction in &gt;500 patients from germany and austria. adding elotuzumab improved vgpr and mrd neg rates in a cohort that included 22-25% of hrmm. ongoing study #mmsm 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma